TABLE 2.
The targets of IL-35 in RA.
Modulators | IL-35 | Target | Model | References |
---|---|---|---|---|
IL-35 | IFN-γ | RA serum | Niedbala et al. 2007 | |
Breg | IL-35 | IL-10 | PBMCs | Wang et al. 2014 |
iTR35 | IL-35 | IL-35 | Mice | Collison et al. 2010 |
IL-35 | TNF-α | FLS | Wu et al. 2016c | |
Endothelial cells | IL-35 | Ang2 | Huvec | Jiang et al. 2016a |
IL-35 | RANKL | FLS | Li et al. 2016a | |
IL-35 | OPG | CIA mice | Li et al. 2016d | |
IL-35 | P-STAT1 | FLS | Wu et al. 2018 | |
IL-35 | VEGF | FLS | Wu et al. 2018 | |
Macrophages | IL-35 | CCR-7 | PBMCs | Peng et al. 2019 |
CD39+CD4+T cells | IL-35 | Foxp3 | Arthritis mice | Filkova et al. 2015 |
Th-17 | IL-35 | IL-17 | Mice spleen cells | Kam et al. 2018b |